CASE HISTORY
A 21-year-old female with no apparent medical history was transferred from an outside hospital for definitive management of a complex tendon injury of her right hand, sustained while operating an electrical table saw. She received antibiotics and a tetanus booster prior to emergency transfer by helicopter to our institution. She reported decreased sensation over the tips of her fingers on the affected hand without specific dermatomal distribution.
On examination, her injuries included complex volar hand lacerations measuring up to 20 cm involving the flexor digitorum superficialis and flexor digitorum profundus, a zone II avulsion of the ring finger and zone III avulsion of the small finger on the ipsilateral hand. She also had a laceration of the radial digital nerve of the thumb, index and middle fingers together with a laceration of the common digital nerve extending to the third web space, a pisiform fracture and small fracture of the volar aspect of thumb at the level of the interphalangeal joint. She was haemodynamically stable with no additional injuries discovered following a secondary survey and preoperative laboratory studies were unremarkable with a leukocyte count of 14,100 /mm 3 , serum electrolytes within normal range (serum sodium 142 mmol/l [normal 135 to 145 mmol/l]) and a haematocrit of 34.3%.
Surgical debridement and repair of the multiple tendon and nerve injuries required approximately eight hours with minimal estimated blood loss (less than 200 ml). Fluid resuscitation intraoperatively included one litre normal saline (NS), three litres Lactated Ringer's (LR), two units packed red blood cells (PRBC) and 500 ml of hydroxyethyl starch. Her intraoperative urinary output was 3050 ml.
Her serum sodium rose steadily from 142 mmol/l on admission to 156 mmol/l intraoperatively. She was, however, extubated without difficulty postoperatively and taken to the post anesthesia care unit where she received additional fluid resuscitation with two litres of LR, had 1600 ml urinary output over the following two hours and remained haemodynamically stable. She had an additional 7425 ml of urinary output over the of 191 mmol/l, potassium 2.6 mmol/l and chloride 156 mmol/l. Urine osmolality was 133 mOsm/kg and urine sodium was 48 mmol/l. She was normoglycaemic at 7.2 mmol/l (normal 4 to 6.1 mmol/l). She had a low-grade fever that eventually peaked four hours later at 40°C. She immediately received three litres of LR as well as empiric broad spectrum antibiotic coverage following the acquisition of blood, sputum and urine samples for microbiological analysis.
Despite aggressive fluid resuscitation, she developed refractory hypotension and required low-dose vasopressor (noradrenaline) infusion over the ensuing 10 hours to maintain a mean arterial pressure of 65 mmHg. A cortisol stimulation test ensuing eight hours. Her haematocrit on postoperative day one was 24.1% and she received two units PRBCs.
Approximately 24 hours after her initial presentation, she developed an altered mental status with initial confusion and agitation that progressed to an unresponsive state. Concomitant tachycardia and hypotension necessitated emergency transfer to the surgical intensive care unit where she required urgent intubation and placement of central venous and arterial access for haemodynamic monitoring.
Her initial laboratory results on intensive care unit admission were notable for a serum sodium was performed to evaluate adrenal insufficiency. Baseline blood cortisol was 11.1 μg/dl and delta cortisol after the administration of 250 μg of cosyntropin was 9.8 μg/dl. Low dose hydrocortisone therapy was initiated. Repeat serum analysis demonstrated sodium of 188 mmol/l with a calculated free water deficit in excess of 10 litres. Suspicion was now heightened implicating diabetes inspidus as the cause of her profound hypernatraemia.
A collateral history retrospectively obtained from family members revealed that over the previous year she had developed significant polydipsia, routinely drinking up to 10 litres of water a day with a continuous insistence for copious amounts of ice cold water throughout the night and having to wake from sleep up to six times a night to urinate. Clinical tests for diabetes mellitus by her primary care physician had reportedly been negative. Furthermore, these symptoms had been unprecedented in the family.
In order to differentiate between central and nephrogenic diabetes insipidus, we administered a dose of 16 micrograms of desmopressin (DDAVP) intravenously at 1500 hours. An aggressive free water resuscitation regimen was initiated comprising dextrose 5% in 1/4 N saline at 300 ml/h continuously and dextrose 5% in 1/2 N saline at a 1:1 volume ratio to match urinary output per hour. In addition, she had a constant infusion of free water via a nasoenteric tube at a rate of 100 ml/h with aggressive potassium and phosphate repletion.
Within three hours (1800) of commencing this therapy her urinary output decreased from approximately 500 ml/h to 50 ml/h. Her serum sodium, measured every two hours starting at 1600 hours began a steady decline, falling from 187 to 157 mmol/l. Between 1200 and 1830 hours her urine osmolality increased from 133 to 587 mOsm/kg (normal 50 to 1400 mOsm/kg) and her urine sodium increased from 48 to 171 mmol/l (normal 75 to 300 mmo/l) over the same duration. Her blood pressure normalised and she was weaned off the vasopressor support.
With a presumptive diagnosis of central diabetes inspidus (CDI) we commenced a regimen of intravenous DDAVP (2 μg) twice a day. She underwent a brain MRI that demonstrated increased signal in the posterior pituitary on T1-weighted imaging which was consistent with, although not necessarily pathognomonic for, a diagnosis of CDI. Her serum sodium was 144 mmol/l by 1500 hours on the following day (approximately 24 hours later). Her intravenous fluid rates were consequently decreased and her DDAVP reduced to avoid hyponatraemia and oliguria.
For the remaining course of her hospitalisation, the DDAVP dose was titrated based on the serum sodium and urinary output and she continued to require electrolyte repletion. Antibiotics were discontinued after 48 hours following no positive cultures. Anterior pituitary studies (cortisol, free T4) were within normal limits. Her thyroid stimulating hormone was 2.5 mIU/l (normal 0.4 to 5.5 mIU/l) and luteinizing hormone was 10.5 IU/l (normal 1.1 to 11.1 IU/l). The dose of DDAVP was reduced to one microgram intravenously daily. She was extubated two days later without event. Her mental and neurologic status normalised over the next 24 hours.
DISCUSSION
Hypernatraemia is an uncommon finding in postoperative surgical patients. It is defined as serum sodium greater than 150 mmol/l 1 . Few patients are admitted with hypernatraemia. In a prospective cohort study of the incidence and outcome for general medical-surgical hospital patients with hypernatraemia, less than a quarter were found to be hypernatraemic on admission while the majority developed hypernatraemia in hospital 2 . Hospital-acquired hypernatraemia primarily resulted from inappropriate fluid prescription to patients with increased water losses, impaired thirst or restricted free water intake. In the case presented, the condition was present on admission.
The suspicion of pathological hypernatraemia prompted a diagnostic workup to evaluate potential aetiologies 3, 4 . CDI is a rare cause of hypernatraemia in young adults such as the woman in this case 5 . It is a potentially life-threatening condition. She presented in near classical manner with polyuria (greater than three litres in 24 hours) and polydipsia due to the deficiency of arginine vasopressin (ADH). This occurs due to destruction or degeneration of the supraoptic and paraventricular nuclei of the posterior hypothalamus. The condition manifests as an inability to conserve water and maintain an optimum free water level 6 . This young woman passed copious amounts of diluted urine regardless of her state of hydration. This served to trigger extraordinary thirst hitherto resulting in a corresponding copious water intake. Thus prior to admission, she had probably maintained a relatively normal or high normal osmotic concentration of plasma 7 . Tight water balance regulation maintains osmotic concentration within 2% of baseline 8 . Central diabetes insipidus may be attributed to an inadequate release of ADH for various reasons, both congenital and acquired. An inadequate response of the kidney, however, to ADH results in nephrogenic diabetes insipidus and both constitute distinct clinical entities.
Central diabetes inspidus is rare and initially remained lower on our list of differential diagnoses. The vast majority of the ADH secreting neurones must be destroyed before it becomes clinically 4 . Causes are congenital and acquired. The acquired causes include head trauma, infiltrative diseases such as Langerhan's cell histiocytosis, surgery, neoplasms such as craniopharyngioma, germinoma, and autoimmune conditions such as Wegener's granulomatosis, vascular or idiopathic [8] [9] [10] [11] [12] [13] . Intrasellar resections account for up to 15% of postoperative CDI with suprasellar and craniopharygioma resections comprising 40% and 90% respectively 4, 14 . Many patients with acquired causes of CDI tend to have circulating antibodies against ADH cells and subsequently develop other autoimmune conditions such as thyroid disease 4, 15, 16 . These patients benefit from continued surveillance for future endocrinopathies and the patient in this case was duly evaluated by the hospital endocrine service. Common aetiologies of CDI are enumerated in Table 1 . Most are idiopathic 4, 13 . Recent increases, however, in both motor vehicle accidents and in patients undergoing pituitary surgery have decreased the proportion of cases previously attributed to idiopathic causes. This percentage is also likely to continue to fall as more obscure pathological causes are identified 4, 15 . Nephrogenic diabetes insipidus occurs more commonly than CDI, most frequently from lithium toxicity accounting for 15 to 40% of causes. Apart from drug toxicities, other causes of nephrogenic diabetes insipidus include metabolic abnormalities such as hypercalcaemia, hypothyroidism and chronic renal disease. In this latter condition, the posterior pituitary is appropriately stimulated by the increased plasma osmolality and duly produces sufficient ADH to which the kidney is unable to respond. As a result, the kidney fails to maximally concentrate the urine 6, 17 .
Urine osmolality of less than 200 mOsmol/kg in the presence of polyuria is pathognomonic of CDI. A water deprivation test involving withholding of free water to stimulate ADH secretion may be used but is not necessary for the diagnosis. Deprivation may last up to 18 hours with hourly measurements of body weight and urine osmolality until two consecutive samples varying by less than 30 mOsm/kg (or <10%) or until the patient loses 5% of his or her body weight. Plasma osmolality is also measured. An ADH level is then measured followed by the administration of five units of synthetic ADH or 1 μg of desmopressin (DDAVP, a synthetic analogue of ADH). Osmolality is then remeasured at 30 and 60 minutes. In normal patients and those with psychogenic polydipsia, urine osmolality exceeds plasma osmolality following fluid restriction and urine osmolality increases only marginally in response to ADH/DDAVP. In central diabetes insipidus, urine osmolality remains less than plasma osmolality after dehydration. Following administration of DDAVP however, urine osmolality increases by more than 50% 18 . Urine output simultaneously falls precipitously as illustrated in this case. Nephrogenic diabetes insipidus, in contradistinction, is characterised by urine osmolality that increases by less than 50%. At least half the patients with CDI also demonstrate anterior pituitary hormone deficiency at a later stage of their disease 13 . In the case presented, the patient was inadvertently exposed to a water deprivation test by fasting prior to and during transportation to our facility. She had limited access to water for the entire duration before, during and after her surgical procedure and was unable to compensate for her water deficit, despite an intact thirst mechanism. With a Foley catheter in situ, she continued to have copious urine output resulting in a profound hypernatraemia. CDI may also be associated with a thickened pituitary stalk and hyperintensity of the posterior pituitary seen on sagittal T1-weighted MR imaging [19] [20] [21] [22] and for this reason she also underwent MRI scanning.
The acute management of severe hypernatraemia requires aggressive free water replacement. Treatment was thus directed at maintenance of a normal circulatory volume while correcting the serum sodium with free water replacement. The initial calculation of the free water deficit helped to estimate the free water replacement required. This deficit should ideally be replaced over 48 to 72 hours. We achieved the replacement using intravenous 5% dextrose and water via a nasoenteric 23 . Meticulous monitoring of urine and plasma osmolality should accompany replacement to avoid overcorrection and additionally to guide the pace of correction. Correction of hypernatraemia and free water deficit that is too rapid may result in pulmonary and cerebral oedema. With this in mind, a correction pace of 0.5 mEq/l per hour is generally recommended. The pace, however, may be adjusted according to the duration over which the hypernatraemia developed. In this report the patient's serum sodium increased from a normal value of 142 mmol/l to 191 mmol/l in less than 24 hours. This abnormality could, in turn, be corrected over the same duration without any adverse sequelae and no demonstrable neurologic or pulmonary deficits.
We used DDAVP both as a diagnostic tool and as a therapeutic agent. Once administered, urine volume decreased and urine osmolality increased and normalised. DDAVP may be administered parenterally, orally or intranasally. Typically a 10 μg dose is given at night. This relieves nocturia and may be repeated in the morning for daytime symptoms. Dosage and scheduling are in this way individually tailored. ADH administration as a purified preparation called pitressin may be given intramuscularly every two to four days and provides relieve for up to three days. Side-effects include abdominal pain, chest pain and hypertension. Chlorpropamide, carbamazepine and clofibrate are similarly used albeit less frequently. Thiazide derivatives are used as a last resort. They serve to decrease distal tubule sodium and chloride absorption, enhancing sodium and water absorption in the proximal tubule 24 . We did not have to resort to any of these latter drugs.
CONCLUSION
CDI is a rare life-threatening cause of severe perioperative hypernatraemia. In this case report and review of the literature we have discussed the management, diagnosis, causes and treatment of hypernatraemia secondary to idiopathic central diabetes insipidus. By heightened suspicion for and awareness about this rare condition and by utilising a multidisciplinary approach, we corrected the electrolyte abnormality over 24 hours with no adverse neurological or clinical sequelae.
